Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 4, 2016, Pages 425-432

  Yi, Hyon Ah ^a,b   Möller, Christiane ^a   Dieleman, Nikki ^a,c   Bouwman, Femke H ^a   Barkhof, Frederik ^d   Scheltens, Philip ^a   Van Der Flier, Wiesje M ^a,d   Vrenken, Hugo ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Keimyung University   (South Korea)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; CAUDATE NUCLEUS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLOBUS PALLIDUS; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; SYMPTOMATOLOGY; THALAMUS; AGE; ATROPHY; EDUCATIONAL STATUS; IMAGE PROCESSING; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGY; SEX DIFFERENCE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; SEX FACTORS;

EID: 84962183182     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309105     Document Type: Article

References (40)

1. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-94.
2. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol 2009;66:1447-55.
3. Farias ST, Mungas D, Reed BR, et al. Progression of mild cognitive impairment to dementia in clinic-vs community-based cohorts. Arch Neurol 2009;66:1151-7.
4. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
5. Atiya M, Hyman BT, Albert MS, et al. Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review. Alzheimer Dis Assoc Disord 2003;17:177-95.
6. Braak H, Braak E. Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol 1991;81:261-8.
7. Braak H, Braak E. Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol 1990;49:215-24.
8. Knight WD, Okello AA, Ryan NS, et al. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain 2011;134(pt 1):293-300.
9. Villemagne VL, Ataka S, Mizuno T, et al. Highstriatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol 2009;66:1537-44.
10. de Jong LW, van der Hiele K, Veer IM, et al. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain 2008;131:3277-85.
11. Roh JH, Qiu A, Seo SW, et al. Volume reduction in subcortical regions according to severity of Alzheimer's disease. J Neurol 2011;258:1013-20.
12. Pievani M, Bocchetta M, Boccardi M, et al. Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study. Neurobiol Aging 2013;34:1728-39.
13. Liu Y, Paajanen T, Zhang Y, et al. Analysis of regional MRI volumes and thickness as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging 2010;31:1375-85.
14. Cherubini A, Peran P, Spoletini I, et al. Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. J Alzheimers Dis 2010;19:1273-82.
15. Tang X, Holland D, Dale AM, et al. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting. Hum Brain Mapp 2014;35:3701-25.
16. van der Flier WM, Pijnenburg YA, Prins N, et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. J Alzheimers Dis 2014;41:313-27.
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
18. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
19. Roth M, Huppert FA, Mountjoy CQ, et al. The Cambridge Examination for Mental Disorders of the Elderly-Revised. Cambridge: Cambridge University Press, 1999.
20. Patenaude B, Smith SM, Kennedy DN, et al. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907-22.
21. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1. 5T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-6.
22. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479-89.
23. Popescu V, Battaglini M, Hoogstrate WS, et al. Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3DT images in multiple sclerosis. Neuroimage 2012;61:1484-94.
24. Babalola KO, Patenaude B, Aljabar P, et al. An evaluation of four automatic methods of segmenting the subcortical structures in the brain. Neuroimage 2009;47:1435-47.
25. Mann DMA. The topographic distribution of brain atrophy in Alzheimer's disease. Acta Neuropathol 1991;83:81-6.
26. Risacher SL, Saykin AJ, West JD, et al. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 2009;6:347-61.
27. Stepan-Buksakowska I, Szabo N, Horinek D, et al. Cortical and subcortical atrophy in Alzheimer disease: parallel atrophy of thalamus and hippocampus. Alzheimer Dis Assoc Disord 2014;28:65-72.
28. de Jong LW, Wang Y, White LR, et al. Ventral striatal volume is associated with cognitive decline in older people; a population based MR-study. Neurobiol Aging 2012;33:424.e1-10.
29. Eckerstrom C, Olsson E, Borga M, et al. Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: The Goteborg MCI study. J Neurol Sci 2008;272:48-59.
30. Leung KK, Bartlett JW, Barnes J, et al. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology 2013;80:648-54.
31. Fleisher AS, Sun S, Taylor C, et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 2008;70:191-9.
32. Bruen PD, McGeown WJ, Shanks MF, et al. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. Brain 2008;131(pt 9):2455-63.
33. Piccininni M, Di Carlo A, Baldereschi M, et al. Behavioral and psychological symptoms in Alzheimer's disease: frequency and relationship with duration and severity of the disease. Dement Geriatr Cogn Disord 2005;19:276-81.
34. Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002;53:647-54.
35. Landau SM, Harvey D, Madison CM, et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010;75:230-8.
36. Ahn HJ, Seo SW, Chin JH, et al. The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer's disease: a surface-based morphometric analysis. Neuropsychologia 2011;49:3931-45.
37. Henneman WJP, Sluimer JD, Barnes J, et al. Hippocampal atrophy rates in Alzheimer disease. Neurology 2009;72:999-1007.
38. Lee GJ, Lu PH, Medina LD, et al. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations. J Neuol Neurosurg Psychiatry 2013;84:154-62.
39. Klekociuk SZ, Summers MJ. Exploring the validity of mild cognitive impairment (MCI) subtypes: multiple-domain amnestic MCI is the only identifiable subtype at longitudinal follow-up. J Clin Exp Neuropsychol 2014;36:290-301.
40. Han JW, Kim TH, Lee SB, et al. Predictive validity and diagnostic stability of mild cognitive impairment subtypes. Alzheimers Dement 2012;8:553-9.